Business & Regulation

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

Our priorities paint a picture of who we are, and that’s as true in RNAi medicine development as it is elsewhere in life

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

Applied correctly, data can do almost anything

It’s a fact that the pharma industry is dominated by white men. What does this mean for people from different ethnic backgrounds?

From video games to climate change; looking back on a handful of articles from 2022.

Who do we blame for the return of polio?

In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?